Literature DB >> 25130165

Comparative nutritional and chemical phenome of Clostridium difficile isolates determined using phenotype microarrays.

Joy Scaria1, Jenn-Wei Chen1, Nicodemus Useh1, Hongxuan He2, Sean P McDonough3, Chunhong Mao4, Bruno Sobral4, Yung-Fu Chang5.   

Abstract

OBJECTIVES: Clostridium difficile infection (CDI) is the leading cause of infectious diarrhea in North America and Europe. The risk of CDI increases significantly in the case where antimicrobial treatment reduces the number of competing bacteria in the gut, thus leading to the increased availability of nutrients and loss of colonization resistance. The objective of this study was to determine comprehensive nutritional utilization and the chemical sensitivity profile of historic and newer C. difficile isolates and to examine the possible role of the phenotype diversity in C. difficile virulence.
METHODS: Phenotype microarrays (PMs) were used to elucidate the complete nutritional and chemical sensitivity profile of six C. difficile isolates.
RESULTS: Of the 760 nutrient sources tested, 285 compounds were utilized by at least one strain. Among the C. difficile isolates compared, R20291, a recent hypervirulent outbreak-associated strain, appears to have an expanded nutrient utilization profile when compared to all other strains.
CONCLUSIONS: The expanded nutritional utilization profile of some newer C. difficile strains could be one of the reasons for infections in patients who are not exposed to the hospital environment or not undergoing antibiotic treatment. This nutritional profile could be used to design tube feeding formulas that reduce the risk of CDI.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Metabolism; Phenome; Phenotype; Phenotype microarray

Mesh:

Year:  2014        PMID: 25130165      PMCID: PMC4197074          DOI: 10.1016/j.ijid.2014.06.018

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  43 in total

1.  High-throughput generation, optimization and analysis of genome-scale metabolic models.

Authors:  Christopher S Henry; Matthew DeJongh; Aaron A Best; Paul M Frybarger; Ben Linsay; Rick L Stevens
Journal:  Nat Biotechnol       Date:  2010-08-29       Impact factor: 54.908

Review 2.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

Review 4.  Global phenotypic characterization of bacteria.

Authors:  Barry R Bochner
Journal:  FEMS Microbiol Rev       Date:  2008-11-27       Impact factor: 16.408

5.  Analysis of ultra low genome conservation in Clostridium difficile.

Authors:  Joy Scaria; Lalit Ponnala; Tavan Janvilisri; Weiwei Yan; Lukas A Mueller; Yung-Fu Chang
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

6.  Microarray identification of Clostridium difficile core components and divergent regions associated with host origin.

Authors:  Tavan Janvilisri; Joy Scaria; Angela D Thompson; Ainsley Nicholson; Brandi M Limbago; Luis G Arroyo; J Glenn Songer; Yrjö T Gröhn; Yung-Fu Chang
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

7.  Beneficial role of green plantain [Musa paradisiaca] in the management of persistent diarrhea: a prospective randomized trial.

Authors:  Thais Alvarez-Acosta; Cira León; Salvador Acosta-González; Haydeé Parra-Soto; Isabel Cluet-Rodriguez; Maria Rosario Rossell; José A Colina-Chourio
Journal:  J Am Coll Nutr       Date:  2009-04       Impact factor: 3.169

8.  Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial.

Authors:  Golam H Rabbani; Shamsir Ahmed; Iqbal Hossain; Rafiqul Islam; Farzana Marni; Mastura Akhtar; Nashiha Majid
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 9.  Tube feeding, the microbiota, and Clostridium difficile infection.

Authors:  Stephen J D O'Keefe
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more
  12 in total

Review 1.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 2.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

3.  The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Authors:  Daniela Wetzel; Shonna M McBride
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

4.  Diverse Energy-Conserving Pathways in Clostridium difficile: Growth in the Absence of Amino Acid Stickland Acceptors and the Role of the Wood-Ljungdahl Pathway.

Authors:  Simonida Gencic; David A Grahame
Journal:  J Bacteriol       Date:  2020-09-23       Impact factor: 3.490

5.  Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer.

Authors:  Melinda A Engevik; Amy C Engevik; Kristen A Engevik; Jennifer M Auchtung; Alexandra L Chang-Graham; Wenly Ruan; Ruth Ann Luna; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  ACS Infect Dis       Date:  2020-11-11       Impact factor: 5.084

6.  Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis.

Authors:  Kathryn L Nawrocki; Daniela Wetzel; Joshua B Jones; Emily C Woods; Shonna M McBride
Journal:  Environ Microbiol       Date:  2018-02-09       Impact factor: 5.491

7.  Comparative genomic and phenomic analysis of Clostridium difficile and Clostridium sordellii, two related pathogens with differing host tissue preference.

Authors:  Joy Scaria; Haruo Suzuki; Christopher P Ptak; Jenn-Wei Chen; Yongzhang Zhu; Xiao-Kui Guo; Yung-Fu Chang
Journal:  BMC Genomics       Date:  2015-06-10       Impact factor: 3.969

Review 8.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

9.  Using phenotype microarrays in the assessment of the antibiotic susceptibility profile of bacteria isolated from wastewater in on-site treatment facilities.

Authors:  Łukasz Jałowiecki; Joanna Chojniak; Elmar Dorgeloh; Berta Hegedusova; Helene Ejhed; Jörgen Magnér; Grażyna Płaza
Journal:  Folia Microbiol (Praha)       Date:  2017-04-27       Impact factor: 2.099

10.  Systems biology analysis of the Clostridioides difficile core-genome contextualizes microenvironmental evolutionary pressures leading to genotypic and phenotypic divergence.

Authors:  Charles J Norsigian; Heather A Danhof; Colleen K Brand; Numan Oezguen; Firas S Midani; Bernhard O Palsson; Tor C Savidge; Robert A Britton; Jennifer K Spinler; Jonathan M Monk
Journal:  NPJ Syst Biol Appl       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.